Table 1 CASES including demographic information, serum levels, and time after ingestion serum were drawn
From: Serum fluoxetine and norfluoxetine levels support the safety of fluoxetine in overdose
Age/sex | BMI | Overdose (mg) | 1st level of F (ng/mL) | 1st level of Norf (ng/mL) | Time after ingestion (hours) for 1st level | 2nd measured level of Fluoxetine | 2nd measured level of NorF | Time after ingestion (hours) for 2nd level |
|---|---|---|---|---|---|---|---|---|
17F | 28.4 | 240 | 139 | 205 | 144 | Not completed | Not completed | Not completed |
16M | 21.1 | 680a | 226 | 255 | 148 | 37 | 165 | 316 |
14F | 20.0 | Unknowna | 464 | 453 | 163 | 338 | 468 | 211 |
15F | 21.6 | 20a | 272 | 80 | 67 | Not completed | Not completed | Not completed |